These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4574486)

  • 1. [Parenteral administration of a new cephalosporin in patients with chronic kidney failure. Study of plasmatic half-life of the antibiotic in relation to glomerular clearance].
    Malandain H; Humbert G; Fillastre JP; Acar J; Dubois D; Leroy J; Robert M; Daufresne MF
    Pathol Biol (Paris); 1973 Mar; 21(3):233-9. PubMed ID: 4574486
    [No Abstract]   [Full Text] [Related]  

  • 2. [Plasmatic half-life of a new cephalosporin in a patient with chronic renal insufficiency].
    Humbert G; Malandain H; Acar J; Fillastre JP
    Nouv Presse Med; 1972 May; 1(21):1438. PubMed ID: 5036700
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serum levels of a new cephalosporin, cephacetrile, as a function of renal excretion capacity].
    Brogard JM; Ruscher H; Frankhauser J; Kuntzmann F; Lavillaureix J
    Pathol Biol (Paris); 1973 Jun; 21(6):671-9. PubMed ID: 4581199
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of the renal metabolism of a sodium salt of cephalosporanic acid. Determination of the half-life, clearance and dialysance of this antibiotic in man].
    Zech P; Pozet N; Monnier JC; Béruard M; Traeger J
    Pathol Biol (Paris); 1974 Apr; 22(4):365-70. PubMed ID: 4603857
    [No Abstract]   [Full Text] [Related]  

  • 5. [The course of serum levels of a new cephalosporin, cephacetrile, as a function of renal elimination capacity].
    Brogard JM; Ruscher H; Frankhauser J; Kuntzmann F; Lavillaureix J
    Arzneimittelforschung; 1974 Sep; 24(9b):1491-7. PubMed ID: 4479810
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical pharmacology of cephalexin administered intravenously.
    De Maine JB; Kirby WM
    Antimicrob Agents Chemother (Bethesda); 1970; 10():190-4. PubMed ID: 5521336
    [No Abstract]   [Full Text] [Related]  

  • 7. [Plasma half-life of cefazoline. Study in the normal subject and in the patient with renal insufficiency].
    Humbert G; Fillastre JP; Leroy A
    Nouv Presse Med; 1975 Oct; 4(35):2523-6. PubMed ID: 1196876
    [No Abstract]   [Full Text] [Related]  

  • 8. Study of the serum half-life of a new cephalosporin in uraemic patients.
    Fillastre JP; Humbert G; Acar J; Malandain H; Robert M; Dubois D; Daufresne MF
    Proc Eur Dial Transplant Assoc; 1972; 9():577-80. PubMed ID: 4668933
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of cefazolin, a new cephalosporin antibiotic, in normal and uraemic patients.
    Leroy A; Canonne MA; Fillastre JP; Humbert G
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):878-89. PubMed ID: 4214662
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of renal failure and hemodialysis on cephacetrile pharmacokinetics.
    Nissenson AR; Levin NW; Parker RH
    Clin Pharmacol Ther; 1972; 13(6):887-94. PubMed ID: 5081601
    [No Abstract]   [Full Text] [Related]  

  • 11. [Plasma half life of a new cephalosporin in uremic patients].
    Fillastre JP; Humbert G; Malandain H; Dubois D; Daufresne MF; Robert M
    J Urol Nephrol (Paris); 1973; 79(4):384. PubMed ID: 4720136
    [No Abstract]   [Full Text] [Related]  

  • 12. Contribution to the pharmacokinetics of a new cephalosporin derivative.
    Dvorácek K; Modr Z; Schmidt O; Necásková A
    Arzneimittelforschung; 1974 Sep; 24(9b):1468-70. PubMed ID: 4479805
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antibacterial activity, pharmacokinetics and clinical use of a new cephalosporin antibiotic cephacetrile].
    Brogard JM; Kuntzmann F; Lavillaureix J
    Arzneimittelforschung; 1974 Sep; 24(9b):1528-33. PubMed ID: 4479819
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of renal insufficiency and hemodialysis on cephacetrile pharmacokinetics].
    Nissenson AR; Levin NW; Parker RH
    Arzneimittelforschung; 1974 Sep; 24(9b):1470-3. PubMed ID: 4479806
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of a new cephalosporin, cephacetrile, in patients with normal and impaired renal function.
    Westenfelder SR; Naber KG; Madsen PO
    Arzneimittelforschung; 1974 Sep; 24(9b):1481-5. PubMed ID: 4479808
    [No Abstract]   [Full Text] [Related]  

  • 16. Cefazolin, a new semisynthetic cephalosporin antibiotic. 3. Absorption, excretion and tissue distribution in parenteral administration.
    Nishida M; Matsubara T; Murakawa T; Mine Y; Yokota Y; Goto S; Kuwahara S
    J Antibiot (Tokyo); 1970 Apr; 23(4):184-94. PubMed ID: 5423363
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics of buflomedil after intravenous administration in patients with chronic renal failure.
    Rey E; d'Athis P; Richard MO; Fillastre JP; Olive G
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):648-52. PubMed ID: 6526539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cefazolin, a new broad-spectrum antibiotic (author's transl)].
    Simon C; Malerczyk V; Brahmstaedt E; Toeller W
    Dtsch Med Wochenschr; 1973 Dec; 98(51):2448-50. PubMed ID: 4767675
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood levels of cephalosporin in patients with chronic kidney insufficiency and with or without hemodialysis].
    Lobuseva AN; Fomina IP; Vasiliev VK; Levitskiĭ ER; Sagalovich OM
    Antibiotiki; 1972 Mar; 17(3):277-80. PubMed ID: 5030782
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug therapy: The newer cephalosporins.
    Moellering RC; Swartz MN
    N Engl J Med; 1976 Jan; 294(1):24-8. PubMed ID: 1105179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.